Pediatria
Estudo randomizado fase 1/2 | CoronaVac é bem tolerada, segura e induz forte resposta humoral em crianças e adolescentes de 3 a 17 anos de idade.
29 Jun, 2021 | 09:54hComentário convidado: COVID-19 vaccines for children younger than 12 years: are we ready? – The Lancet Infectious Diseases
Comentário no Twitter
NEW—A phase 1/2 clinical trial of #CoronaVac in 550 children and adolescents aged 3-17 years in China suggests two doses of the vaccine are safe and generate a strong antibody response. Read in @TheLancetInfDis: https://t.co/eXSagRu1Cs pic.twitter.com/fOKNLUjNwc
— The Lancet (@TheLancet) June 28, 2021
Consenso sobre concussões relaticionadas ao esporte (sport-related concussion – SRC) – “A evidência atual sugere que repouso estrito após SRC retarda a recuperação e aumenta a probabilidade de sintomas prolongados.”
25 Jun, 2021 | 10:35hComunicado de imprensa: Strict Rest Slows Recovery after Sports-Related Concussions – American College of Sports Medicine
CDC | Vacinas de mRNA parecem ter ligação com casos de miocardite e pericardite – 1.226 casos de miocardite ou pericardite foram relatados, a maioria em pessoas com menos de 30 anos de idade.
24 Jun, 2021 | 11:00hVer também: Experts: mRNA COVID-19 vaccines likely tied to heart inflammation – CIDRAP
Relacionados: Case series: 7 cases of myocarditis following mRNA-based COVID-19 vaccination. E Case series: clinical and cardiac magnetic resonance imaging findings of 4 cases of myocarditis following mRNA-based COVID-19 vaccination. E Case series: symptomatic acute myocarditis in 7 adolescents following mRNA COVID-19 vaccination. E CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. E Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. E CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.
Consenso | Minimização do risco de lesão e doença em corredores jovens.
24 Jun, 2021 | 10:51hUnesco e OMS estimulam os países a transformar toda escola em uma escola promotora de saúde.
23 Jun, 2021 | 10:54hComunicado de imprensa: UNESCO and WHO urge countries to make every school a health-promoting school – World Health Organization
Diretriz: WHO guideline on school health services – World Health Organization
Comentário: UNESCO and WHO Launch Initiative to Promote Healthier School Environments – Health Policy Watch
Comentário no Twitter (fio – clique para saber mais)
WHO and @UNESCO urge countries to make every school a health-promoting school, following the Global Standards for Health-promoting Schools that aim to ensure all schools promote life skills, cognitive & socioemotional skills & healthy lifestyles.https://t.co/qnMB3EprR8
— World Health Organization (WHO) (@WHO) June 22, 2021
Tratamento da febre sintomática em crianças: revisão sistemática de diretrizes nacionais e internacionais.
21 Jun, 2021 | 10:46hRevisão | Avanços no diagnóstico e no tratamento da discinesia ciliar primária.
21 Jun, 2021 | 10:46hAdvances in the Diagnosis and Treatment of Primary Ciliary Dyskinesia: A Review – JAMA Otolaryngology – Head & Neck Surgery (gratuito por tempo limitado)
Estudo de coorte | Em crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19, não houve evidência de diferenças na recuperação após tratamento inicial com imunoglobulina intravenosa (IGIV) isolada, IGIV com glicocorticoides ou glicocorticoides isolados.
18 Jun, 2021 | 10:42hTreatment of Multisystem Inflammatory Syndrome in Children – New England Journal of Medicine
Editorial: Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
Comentários: Steroids may be effective treatment for COVID-19 complications in children – Imperial College London E Expert reaction to study looking at treatments for COVID-19 complications in children – Science Media Centre
Estudo de coorte | Em crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19, o tratamento inicial com imunoglobulina intravenosa (IGIV) e glicocorticoides foi associado com menor risco de disfunção cardiovascular nova ou persistente em comparação ao tratamento com IGIV isolada.
18 Jun, 2021 | 10:40hEditorial: Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
Entrevista em áudio | Potenciais tratamentos para crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19.
18 Jun, 2021 | 10:38hAudio Interview: Covid-19 in Children – New England Journal of Medicine


